EVFM
Evofem Biosciences, Inc.
Key Financials
Net Income
$391000
↑ 104.4%
Revenue
$20.2M
↑ 4.2%
EPS (Diluted)
$0.00
↑ 100.0%
Operating Income
$3.4M
↑ 143.9%
Total Assets
$20.3M
↓ 14.8%
Total Liabilities
$89.7M
↓ 0.6%
Shareholders' Equity
$-74336000.00
↓ 4.3%
Long-term Debt
$7.2M
0.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 9/23/2026 | View on SEC |
| 10-Q | 8/14/2026 | View on SEC |
| SCHEDULE 13D | 8/4/2026 | View on SEC |
| 8-K | 7/20/2026 | View on SEC |
| 8-K | 7/14/2026 | View on SEC |
| 8-K | 5/18/2026 | View on SEC |
| 10-Q | 5/15/2026 | View on SEC |
| 8-K | 4/30/2026 | View on SEC |
| 8-K | 4/16/2026 | View on SEC |
| 8-K | 3/19/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | EVFM |
| Company Name | Evofem Biosciences, Inc. |
| CIK | 1618835 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (858) 550-1900 |